Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.14) per share. This is unchanged from the same period last year.
AMD Chief Lisa Su Foresees Massive Gains in AI and Data Center Efficiency
AMD CEO Lisa Su highlighted progress towards 30x25 goal, aiming for 100x improvement by 2026-27 in compute node power efficiency, addressing AI power consumption concerns through silicon advancements, advanced packaging, and software optimization.